Get App

Co-Partners

Associate Partners

Last Updated : Apr 19, 2017 08:52 AM IST | Source: Moneycontrol.com

Glenmark Pharma receives tentative ANDA approval for Dabigatran Etexilate capsules

Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the USFDA for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg, the generic version of Pradaxa Capsules, 75 mg, 110 mg and 150 mg of Boehringer Ingelheim Pharmaceuticals, Inc.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sub:- Glenmark Pharmaceuticals receives tentative ANDA approval for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Thanking You. Yours faithfully, For Glenmark Pharmaceuticals Ltd. Harish Kuber Company Secretary & Compliance OfficerSource : BSE

Read all announcements in Glenmark

First Published on Apr 19, 2017 08:52 am
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant